A new treatment for glaucoma using a hydrogel
Official title: A Novel Non-Drug, Non-Surgical Hydrogel-Based Treatment of Glaucoma
Funded at Emory University · NIH-11089288 · Data updated 2026-11-12
This study is exploring a new way to help people with glaucoma by using a special gel that can be injected into the eye to lower eye pressure without needing daily eye drops or surgery, making it easier for patients to stick to their treatment.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $53,974 |
| NIH project number | 5F30EY035173-02 |
| Project ID | NIH-11089288 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with glaucoma who struggle with adherence to current treatment methods.
✕Less likely to help
Patients who have advanced glaucoma requiring immediate surgical intervention may not benefit from this research.
What this research studies
This research investigates a novel approach to treating glaucoma by using a hydrogel to expand the suprachoroidal space in the eye. The treatment aims to reduce intraocular pressure (IOP) without the need for daily eye drops or surgery, which can be difficult for patients to adhere to. By injecting the hydrogel via a microneedle, the researchers hope to improve the outflow of aqueous humor and maintain lower IOP for an extended period. This method could enhance patient compliance and overall treatment effectiveness.
Why it matters
Potential benefit: If successful, this research could provide a more effective and convenient treatment option for glaucoma patients, potentially reducing the risk of blindness.
How similar studies have gone: Previous studies have shown promising results with similar hydrogel approaches in animal models, indicating potential for success in human applications.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Chung, Yooree Grace — Emory University
- Study coordinator: Chung, Yooree Grace
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Comparing tube positions in glaucoma implants to protect corneal cells
This trial compares two tube placements for glaucoma drainage implants to see which better protects corneal cells and controls eye pressure in people with uncontrolled glaucoma.
-
Automated topographic test for glaucoma detection and progression
A new automated method uses topographic structure-function mapping to help diagnose glaucoma earlier and track its progression in patients.
-
Using AI on eye scans and genes to predict glaucoma risk
This project uses artificial intelligence on eye scans, vision tests, and genetic information to find people most likely to develop or have worsening glaucoma.
-
AI-based glaucoma screening in community health centers
A new, easy-to-use AI screening approach will be tested in federally funded health centers to help identify people at risk for glaucoma, especially in communities with higher risk.
-
Understanding how glaucoma genes control eye cell function
A long-term research project will study how genetic factors affect eye cells in adults with glaucoma to uncover new ideas for protecting vision.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.